Global Nucleic Acid Testing Market Opportunities & Forecast 2018-2025 Global Nucleic Acid Testing Market Opportunities | Page 3

prevalence of infectious diseases and rising adoption of advanced
diagnostic technologies
Key takeaways:
•
Ligase chain reaction segment is expected to exhibit the highest
CAGR of 7.9% during 2018–2025
• North America held the largest share in the market in 2017
• Asia-Pacific is the fastest growing region in the global nucleic acid
testing market and is projected to grow at CAGR of 8.0% during 2018-
2025.
•
Emerging economies, such as China and India are the hotspots for
investment because of larger patient pool, increasing diagnosis
seeking rate and exponential growth in research & development
activities.
Some of the key players operating in the global nucleic acid testing
market, include Abbott Laboratories, Agilent Technologies, Danaher
Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd.,
Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Merck KGaA,
Becton, Dickinson and Company, among others.
The global nucleic acid testing market has been segmented on the
basis of product type, end use and key geographies. Based on the
product type which include different type of nucleic acid test kits, the
nucleic acid kits comprises of polymerase chain reaction (PCR),
transcription-mediated amplification (TMA), ligase chain reaction
(LCR), and whole genome sequencing. Based on end user, the market
has been segmented into hospitals, pathology laboratories, research
institutes and clinics.
The research report “global nucleic acid testing market” provides in-
depth analysis of nucleic acid testing across the globe, based on
product type, end use and major geographies for the forecast period